联环药业：苯磺酸氨氯地平片完成药品注册

Core Viewpoint - The company has received approval from the National Medical Products Administration for its subsidiary's drug, Amlodipine Besylate Tablets, which is commonly used to regulate vascular pressure [1] Group 1 - The drug Amlodipine Besylate Tablets has been officially registered, indicating a significant milestone for the company [1] - The approval enhances the company's product portfolio in the cardiovascular medication sector [1] - Amlodipine Besylate Tablets are recognized as a standard treatment for managing blood pressure [1]